Luis Camílo Ríos Castañeda,Marina Altagracia Martínez,Juan Nader Kawachi,Jaime Kravzov Jinich
申请号：
US10565309
公开号：
US08268893B2
申请日:
2004.03.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The use of dapsone is the first effective treatment against the disabling consequences associated with cerebral infarction in patients. Dapsone was evaluated as a neuroprotector in the cerebral infarction model produced by the occlusion of the middle cerebral artery in rats and in patients suffering from acute cerebral infarction caused by thromboembolism. In both studies, dapsone displayed a reduction of between 70 and 90% in the adverse effects which occur as a consequence of the infarction.
